ADPT — Adaptogenics Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.33m
- CA$0.26m
- CA$0.00m
Annual cashflow statement for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.141 | -0.266 | -0.147 | -0.075 |
| Non-Cash Items | — | — | 0.015 | 0.001 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.004 | -0.006 | 0.019 | 0.006 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.136 | -0.272 | -0.113 | -0.069 |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0.67 | 0 | — | — |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.534 | -0.272 | -0.113 | -0.069 |